MRI does not involve exposure to radiation. It can therefore be safely used to screen women at increased risk of breast cancer who need to have breast screening when they are younger than 40 years of age (when breast tissue is much more sensitive to the effects of radiation).
MRI is the most sensitive test to detect early breast cancer in particular groups of women at high risk. These include women with a known faulty gene that pre-disposes them to developing breast cancer (BRCA 1 or 2 mutation), women with a strong family history of breast cancer and women who have had previous chest radiation treatment for Hodgkin’s disease or other cancer before the age of 30.
The ability of MRI to show abnormalities is not lessened by dense breast tissue (which is common in younger women).
Breast implants can obscure breast tissue during mammography. MRI is the best method to evaluate the breasts of women with implants as it has the ability to show the tissues around the implants in cross-section. MRI is also able to show whether a breast implant has ruptured, where mammography and ultrasound are less accurate.
MRI is the most accurate way of determining the size of a cancer and whether there are other tumours present in the same or other breast. This information may affect the type of surgery needed. This can prevent unnecessary removal of the whole breast (where there is only one small tumour) or under-treatment where only part of the breast is removed (and this does not remove other tumours that mammography and ultrasound may not have shown).
MRI performed halfway into a course of drug therapy can help determine if the drugs are effective.